COVID-19 Records

Transcript segment

Baric Transcribed Interview (Redacted), p.107 · baric_ti:utt:00918

Page text: p.107 · original PDF

Date
2026-04-10 09:00 (day precision)
Type
transcript segment · interview
recipient
Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker
Christina Salazar
But he never raised it. To me it's odd that you wouldn't recall that.

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2026-04-10 09:00 Christina Salazar open
    So up until that point, you had no discussions about the DIFFUSE proposal.
  2. 2026-04-10 09:00 Ralph S. Baric open
    Not that I'm aware of. I was busy on other things.
  3. 2026-04-10 09:00 Christina Salazar open
    There were other people on that grant, so Peter Daszak.
  4. 2026-04-10 09:00 Ralph S. Baric open
    Yes, he would have been there.
  5. 2026-04-10 09:00 Christina Salazar
    But he never raised it. To me it's odd that you wouldn't recall that.
  6. 2026-04-10 09:00 Ralph S. Baric open
    If he would've raised it, I would've remembered it then, because he would've put it in context.
  7. 2026-04-10 09:00 Christina Salazar open
    And he would've told you, right.
  8. 2026-04-10 09:00 Ralph S. Baric open
    Yeah. I think you have to think about where the focus of the research community was. My focuses, at the time, were to rapidly develop mouse models so that we could test mRNA-LNP-based vaccines against SARS-2, to work with Gilead to get their drug forward into clinical trials, to get molnupiravir, a second drug that was FDA approved for use in humans, into clinical trials. DC.Scheduling@LexitasLegal.com
  9. 2026-04-10 09:00 Christina Salazar open
    But, you know, part of the conversation --

Full conversation →